Skip to main content

An updated meta-analysis on association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and cancer risk

Tumor Biology volume 35, pages 6567–6579 (2014)Cite this article

Abstract

The Alu repetitive sequence insertion/deletion (I/D, rs4646994) polymorphism in the angiotensin I-converting enzyme (ACE) gene may alter cancer susceptibility, but results of current studies are inconclusive. To derive a more precise estimation of the relationship between the ACE I/D polymorphism and cancer risk, we performed an updated meta-analysis of all eligible studies. All studies published up to July 2013 concerning the association between the ACE I/D polymorphism and cancer risk were identified by systematically searching PubMed, EMBASE, Wanfang, CNKI, and Cqvip databases. The odds ratios (ORs) with 95 % confidence intervals (CIs) were pooled using the fixed/random-effects model in Review Manager 5.1 and STATA 12.0. A total of 46 case–control studies including 7,025 cases and 34,911 controls were identified and evaluated. Overall, we did not observe a direct association between the ACE I/D polymorphism and general cancer risk (DD + DI vs. II OR = 0.95, 95 %CI = 0.84–1.07, P = 0.40). In the subgroup analysis by cancer type, a significant increased susceptibility of prostate cancer was found for variant homozygotes (DD vs. II + ID OR = 2.15, 95 %CI = 1.01–4.55, P = 0.05). Additionally, no significant association was observed in other subgroup analyses according to ethnicity, control source, sample size and quality control of genotyping. In summary, our results suggested that the ACE I/D polymorphism might not be a common risk factor for overall cancer susceptibility, but might contribute to the susceptibility of prostate cancer. More studies with larger sample sizes are required in the future.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA: a cancer journal for clinicians. 2013;63:11–30.

    Google Scholar 

  2. Risbridger GP, Davis ID, Birrell SN, Tilley WD. Breast and prostate cancer: more similar than different. Nature reviews Cancer. 2010;10:205–12.

    CAS  Article  PubMed  Google Scholar 

  3. Witte JS. Prostate cancer genomics: towards a new understanding. Nature reviews Genetics. 2009;10:77–82.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  4. Berdeli A, Cam FS. Prevalence of the angiotensin I converting enzyme gene insertion/deletion polymorphism in a healthy Turkish population. Biochemical genetics. 2009;47:412–20.

    CAS  Article  PubMed  Google Scholar 

  5. Muscella A, Greco S, Elia MG, Storelli C, Marsigliante S. Angiotensin II stimulation of Na+/K + ATPase activity and cell growth by calcium-independent pathway in MCF-7 breast cancer cells. The Journal of endocrinology. 2002;173:315–23.

    CAS  Article  PubMed  Google Scholar 

  6. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochemical and biophysical research communications. 2002;294:441–7.

    CAS  Article  PubMed  Google Scholar 

  7. Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends in endocrinology and metabolism: TEM. 2005;16:293–9.

    CAS  Article  PubMed  Google Scholar 

  8. Fujita M, Hayashi I, Yamashina S, Fukamizu A, Itoman M, Majima M. Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth. Carcinogenesis. 2005;26:271–9.

    CAS  Article  PubMed  Google Scholar 

  9. Kosaka T, Miyajima A, Takayama E, Kikuchi E, Nakashima J, Ohigashi T, et al. Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer. Prostate. 2007;67:41–9.

    CAS  Article  PubMed  Google Scholar 

  10. Simsek S, Tekes S, Oral D, Turkyilmaz A, Isik B, Isik MR, et al. The insertion/deletion polymorphism in the ACE gene and chronic obstructive pulmonary disease. Genetics and molecular research : GMR. 2013;12:1392–8.

    CAS  Article  PubMed  Google Scholar 

  11. Busquets X, MacFarlane NG, Heine-Suner D, Morla M, Torres-Juan L, Iglesias A, et al. Angiotensin-converting-enzyme gene polymorphisms, smoking and chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease. 2007;2:329–34.

    PubMed Central  CAS  PubMed  Google Scholar 

  12. Ebert MP, Lendeckel U, Westphal S, Dierkes J, Glas J, Folwaczny C, et al. The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005;14:2987–9.

    CAS  Article  Google Scholar 

  13. Freitas-Silva M, Pereira D, Coelho C, Bicho M, Lopes C, Medeiros R. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet. 2004;155:42–6.

    CAS  Article  PubMed  Google Scholar 

  14. Arima H, Kiyohara Y, Tanizaki Y, Nakabeppu Y, Kubo M, Kato I, et al. Angiotensin I-converting enzyme gene polymorphism modifies the smoking-cancer association: the Hisayama Study. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation. 2006;15:196–201.

    CAS  Article  Google Scholar 

  15. Bardi E, Jenei C, Kiss C. Polymorphism of angiotensin converting enzyme is associated with severe circulatory compromise in febrile neutropenic children with cancer. Pediatric blood & cancer. 2005;45:217–21.

    Article  Google Scholar 

  16. Cheon KT, Choi KH, Lee HB, Park SK, Rhee YK, Lee YC. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung. 2000;178:351–60.

    CAS  Article  PubMed  Google Scholar 

  17. Zhang Y, He J, Deng Y, Zhang J, Li X, Xiang Z, et al. The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis. BMC medical genetics. 2011;12:159.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  18. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genetic epidemiology. 2005;28:123–37.

    Article  PubMed  Google Scholar 

  19. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    CAS  Article  PubMed  Google Scholar 

  20. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. Journal of clinical epidemiology. 2008;61:634–45.

    Article  PubMed  Google Scholar 

  21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315:629–34.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327:557–60.

    PubMed Central  Article  PubMed  Google Scholar 

  23. de Martino M, Klatte T, Schatzl G, Waldert M, Remzi M, Haitel A et al. Insertion/deletion polymorphism of angiotensin I-converting enzyme gene is linked with chromophobe renal cell carcinoma. Urology. 2011;77:1005 e9- e13.

    Google Scholar 

  24. Devic Pavlic S, Ristic S, Flego V, Kapovic M, Radojcic BA. Angiotensin-converting enzyme insertion/deletion gene polymorphism in lung cancer patients. Genetic testing and molecular biomarkers. 2012;16:722–5.

    CAS  Article  PubMed  Google Scholar 

  25. Fishchuk LE, Gorovenko NG. Genetic polymorphisms of the renin-angiotensin system in breast cancer patients. Experimental oncology. 2013;35:101–4.

    CAS  PubMed  Google Scholar 

  26. Goto Y, Ando T, Nishio K, Ishida Y, Kawai S, Goto H, et al. The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pacific journal of cancer prevention : APJCP. 2005;6:464–7.

    PubMed  Google Scholar 

  27. Haiman CA, Henderson SO, Bretsky P, Kolonel LN, Henderson BE. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer research. 2003;63:6984–7.

    CAS  PubMed  Google Scholar 

  28. Hibi S, Goto Y, Ando T, Matsuo K, Wakai K, Tajima K, et al. No association between angiotensin I converting enzyme (ACE) I/D polymorphism and gastric cancer risk among Japanese. Nagoya journal of medical science. 2011;73:169–75.

    CAS  PubMed  Google Scholar 

  29. Ji SW. The polymorphism of angiotensin-converting enzyme gene in esopgagus carcinoma patients. Acta Universitatis Medicinalis Anhui. 2012;47.

  30. Koh WP, Yuan JM, Sun CL, van den Berg D, Seow A, Lee HP, et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer research. 2003;63:573–8.

    CAS  PubMed  Google Scholar 

  31. Kupcinskas J, Wex T, Bornschein J, Selgrad M, Leja M, Jonaitis L, et al. Lack of association between gene polymorphisms of angiotensin converting enzyme, nod-like receptor 1, toll-like receptor 4 and FAS/FASL with the presence of helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. Helicobacter. 2011;16:79.

    Article  Google Scholar 

  32. L. SM. The association between ACE ploymorphism and risk of gastric cancer. Chinese Journal of Gerontology. 2011;31.

  33. Li J. Study on association between ACE I/D polymorphism and glioma. Chin J Neurosurg Dis Res. 2013.

  34. Li ZH, Pan XM, Han BW, Han HB, Zhang Z, Gao LB. No association between ACE polymorphism and risk of nasopharyngeal carcinoma. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2012;13:210–5.

    CAS  Article  PubMed  Google Scholar 

  35. Liu SY, Sima X, Wang CH, Gao M. The association between ACE polymorphism and risk of colorectal cancer in a Chinese population. Clinical biochemistry. 2011;44:1223–6.

    CAS  Article  PubMed  Google Scholar 

  36. Liu YT, Lin LW, Chen CY, Wang CP, Liu HP, Houng JY, et al. Polymorphism of angiotensin I-converting enzyme gene is related to oral cancer and lymph node metastasis in male betel quid chewers. Oral oncology. 2012;48:1257–62.

    CAS  Article  PubMed  Google Scholar 

  37. Lukic S, Nikolic A, Alempijevic T, Popovic D, Sokic Milutinovic A, Ugljesic M, et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in patients with chronic pancreatitis and pancreatic cancer. Digestive surgery. 2011;28:258–62.

    CAS  Article  PubMed  Google Scholar 

  38. Mendizabal-Ruiz AP, Morales J, Castro Martinez X, Gutierrez Rubio SA, Valdez L, Vasquez-Camacho JG, et al. RAS polymorphisms in cancerous and benign breast tissue. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2011;12:85–92.

    CAS  Article  PubMed  Google Scholar 

  39. Nacak M, Nacak I, Sanl SM, Ozkur M, Pektas M, Aynacioglu AT. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in turkey. Cancer Genet Cytogenet. 2010;198:22–6.

    CAS  Article  PubMed  Google Scholar 

  40. Namazi S, Monabati A, Ardeshir-Rouhani-Fard S, Azarpira N. Lack of association of genetic polymorphisms of angiotensin converting enzyme 1 and angiotensin II type 1 receptor with breast cancer risk in Iranian population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2013.

  41. Nikiteas N, Tsigris C, Chatzitheofylaktou A, Yannopoulos A. No association with risk for colorectal cancer of the insertion/deletion polymorphism which affects levels of angiotensin-converting enzyme. In vivo (Athens, Greece). 2007;21:1065–8.

    CAS  Google Scholar 

  42. Rocken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B, et al. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005;11:2526–30.

    Article  Google Scholar 

  43. Rocken C, Neumann K, Carl-McGrath S, Lage H, Ebert MPA, Dierkes J, et al. The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. Neoplasia. 2007;9:716–22.

    PubMed Central  Article  PubMed  Google Scholar 

  44. Sierra Diaz E, Sanchez Corona J, Rosales Gomez RC, Gutierrez Rubio SA, Vazquez Camacho JG, Solano Moreno H, et al. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2009;10:241–6.

    Article  PubMed  Google Scholar 

  45. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2006;15:1929–34.

    CAS  Article  Google Scholar 

  46. Tunny TJ, Xu L, Richardson KA, Stowasser M, Gartside M, Gordon RD. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma. Journal of human hypertension. 1996;10:827–30.

    CAS  PubMed  Google Scholar 

  47. Vairaktaris E, Serefoglou Z, Avgoustidis D, Yapijakis C, Critselis E, Vylliotis A, et al. Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral oncology. 2009;45:247–53.

    CAS  Article  PubMed  Google Scholar 

  48. Vasku V, Vasku JA, Goldbergova MP, Vasku A. Association of variants in angiotensin-converting enzyme and endothelin-1 genes with phototherapy in cutaneous T-cell lymphoma. Acta Dermatovenerologica Alpina, Pannonica et Adriatica. 2004;13:111–8.

    CAS  Google Scholar 

  49. Wang HW. Angiotensin converting enzyme gene polymorphism in patients with lung carcinoma. Journal of Navy Medcine. 2000;21.

  50. Wang X, Wang S, Lin YW, Wu J, Chen H, Mao YQ, et al. Angiotensin-converting enzyme insertion/deletion polymorphism and the risk of prostate cancer in the Han population of China. Medical oncology (Northwood, London, England). 2012;29:1964–71.

    CAS  Article  Google Scholar 

  51. Yapijakis C, Koronellos N, Spyridonidou S, Vylliotis A, Avgoustidis D, Goutas N, et al. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma. Archives of dermatological research. 2013;305:333–9.

    CAS  Article  PubMed  Google Scholar 

  52. Yaren A, Oztop I, Turgut S, Turgut G, Degirmencioglu S, Demirpence M. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. Experimental biology and medicine (Maywood, NJ). 2008;233:32–7.

    CAS  Article  Google Scholar 

  53. Yigit B, Bozkurt N, Narter F, Yilmaz H, Yucebas E, Isbir T. Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis. Anticancer research. 2007;27:933–6.

    CAS  PubMed  Google Scholar 

  54. Yuan F, Zhang LS, Li HY, Liao M, Lv M, Zhang C. Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China. DNA and cell biology. 2013;32:268–73.

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  55. Zhang Q, Liu X, Zhang Z, Wang L. Analysis of the relationship between polymorphism of angiotensin-converting enzyme gene and lung cancer. Zhongguo fei ai za zhi, Chinese journal of lung cancer. 2005;8:211–4.

    CAS  PubMed  Google Scholar 

  56. Zhou L. Polymorphism of angiotensin I converting enzyme gene in peripheral blood of colon cancer patients. Cancer Research on Prevention and Treatment. 2010;37.

  57. van der Knaap R, Siemes C, Coebergh JW, van Duijn CM, Hofman A, Stricker BH. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer. 2008;112:748–57.

    Article  PubMed  Google Scholar 

  58. Toma M, Cimponeriu D, Apostol P, Stavarachi M, Cojocaru M, Belusica L, et al. Lack of association between ACE ID polymorphism and colorectal cancer in Romanian patients. Chirurgia (Bucharest, Romania : 1990). 2009;104:553–6.

    CAS  Google Scholar 

  59. Holla L, Vasku A, Soucek M, Krahulcova E, Hajek D, Znojil V. Angiotensin-converting enzyme gene polymorphism and blood groups of the ABO system in leukaemias compared with controls and hypertensives. Scripta Medica Facultatis Medicae Universitatis Brunensis Masarykianae. 1998;71:471–7.

    CAS  Google Scholar 

  60. Gao M, Wang Y, Shi Y, Liu D, Liang Y, Yu Y, et al. The relationship between three well-characterized polymorphisms of the angiotensin converting enzyme gene and lung cancer risk: a case-control study and a meta-analysis. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2012;13:455–60.

    Article  PubMed  Google Scholar 

  61. Liu JF, Xie HJ, Cheng TM. Lack of any association between insertion/deletion (I/D) polymorphisms in the angiotensin-converting enzyme gene and digestive system cancer risk: a meta-analysis. Asian Pacific journal of cancer prevention : APJCP. 2013;14:7271–5.

    Article  PubMed  Google Scholar 

  62. Xi B, Zeng T, Liu L, Liang Y, Liu W, Hu Y, et al. Association between polymorphisms of the renin-angiotensin system genes and breast cancer risk: a meta-analysis. Breast cancer research and treatment. 2011;130:561–8.

    CAS  Article  PubMed  Google Scholar 

  63. Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, et al. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Molecular cancer therapeutics. 2003;2:1139–47.

    CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Affiliations

  1. Department of Neurosurgery, West China Hospital, Sichuan University, 37 Guo Xue Street, Chengdu, Sichuan, 610041, People’s Republic of China

    Yuebing Xie, Chao You & Jing Chen

Authors
  1. Yuebing Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chao You
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing Chen.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Xie, Y., You, C. & Chen, J. An updated meta-analysis on association between angiotensin I-converting enzyme gene insertion/deletion polymorphism and cancer risk. Tumor Biol. 35, 6567–6579 (2014). https://doi.org/10.1007/s13277-014-1842-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1842-z

Keywords

  • ACE
  • Polymorphism
  • Cancer
  • Susceptibility
  • Updated meta-analysis